摘要
Nadine HAMADA MOUSTAFA 医师
皮肤科医师
Tear trough filler correction tips - The ongoing challenge
Objectives: Tear trough area correction has always been an ongoing challenge, the aim of this review is to get a proper guide for the proper tear trough correction that shall keep good results and avoid complications.
Introduction: The eye is one of the most attractive aesthetic units at the same time its one of the areas that shows early sings of aging after over 8 years treating this area I can conclude that the key for proper treatment lies in the TT cause identification and proper patient selection for this procedure. Also more important than the type of HA fillers used the amounts and technique of injection to obtain the best results.
Materials / method: Proper Patient examination ( snap test for the skin quality, pigmentation , make sure of having HA filler ( medium cross link) , an average amount of 0.2-0.4 cc is maximally used per side.
25G, 50 mm long canula is used .
Injection must be placed deep (supra periosteaum).
under correction is recommended with only 70-80% maximum correction.
Re-consultation after 2 weeks is recommended.
Correction of the cheek defect is a must before TT treatment.
It's crucial to avoid any harsh motion or struggle with the canula to void edema.
The treatment is recommended not to be repeated before 6 months.
Results: Improvement of the tear trough with overall satisfactory results.
Complications reports were minimal (out of the 7 presented cases only 2 reported mild edema and only one of them reported tenderness that disappeared after 1 week).
Conclusion: With proper patient selection, proper injection technique TT can be safely corrected.
Filler migration can be avoided by under-correction , avoiding too much material injection, avoiding harsh massage and the use of a light to maximum medium cross linked filler.
Avoiding patients with massive edema and patients with massive laxity is important to avoid complications.
披露 - Nadine HAMADA MOUSTAFA
> 您是否获得了任何资金来支持您关于这个主题的研究?
不是
> 您在这项研究工作中是否获得过任何酬金、报酬或其他形式的补偿?
不是
> 您是否与任何可能与您研究中涉及的药物、材料或器械存在激烈竞争的实体有任何财务关系?
不是
> 您是否拥有或已申请过与您研究中所讨论的仪器、药物或材料相关的任何专利?
不是
这项工作没有任何直接或间接的资金支持。由作者自己承担责任。
Published on 2024年 3月 22日 - Recorded during IMCAS World Congress 2024